Role of angiotensin receptor-neprilysin inhibitor in diabetic complications
Journal article
Liu, Ying, Lu, Cun-Yu, Zheng, Yi, Zhang, Yu-Min, Qian, Ling-Ling, Li, Ku-Lin, Tse, Gary, Wang, Ru-Xing and Liu, Tong 2024. Role of angiotensin receptor-neprilysin inhibitor in diabetic complications. World Journal of Diabetes. 15 (5), pp. 867-875. https://doi.org/10.4239/wjd.v15.i5.867
Authors | Liu, Ying, Lu, Cun-Yu, Zheng, Yi, Zhang, Yu-Min, Qian, Ling-Ling, Li, Ku-Lin, Tse, Gary, Wang, Ru-Xing and Liu, Tong |
---|---|
Abstract | Diabetes mellitus is a prevalent disorder with multi-system manifestations, causing a significant burden in terms of disability and deaths globally. Angio-tensin receptor-neprilysin inhibitor (ARNI) belongs to a class of medications for treating heart failure, with the benefits of reducing hospitalization rates and mortality. This review mainly focuses on the clinical and basic investigations related to ARNI and diabetic complications, discussing possible physiological and molecular mechanisms, with insights for future applications. [Abstract copyright: ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.] |
Keywords | Complication; Diabetic mellitus; Angiotensin receptor-neprilysin inhibitor |
Year | 2024 |
Journal | World Journal of Diabetes |
Journal citation | 15 (5), pp. 867-875 |
Publisher | Baishideng Publishing Group |
ISSN | 1948-9358 |
Digital Object Identifier (DOI) | https://doi.org/10.4239/wjd.v15.i5.867 |
Official URL | https://www.wjgnet.com/1948-9358/full/v15/i5/867.htm |
Publication dates | |
15 May 2024 | |
Publication process dates | |
Accepted | 25 Mar 2024 |
Deposited | 05 Jun 2024 |
Publisher's version | License All rights reserved |
Output status | Published |
Permalink -
https://repository.canterbury.ac.uk/item/980wz/role-of-angiotensin-receptor-neprilysin-inhibitor-in-diabetic-complications
Download files
38
total views9
total downloads9
views this month0
downloads this month